Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TLIS - Talis Biomedical Corp


IEX Last Trade
4.41
0.250   5.669%

Share volume: 51,017
Last Updated: Fri 30 Aug 2024 09:17:36 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$4.16
0.25
6.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
13%
Profitability 0%
Dept financing 11%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
-3.07%
1 Month
-48.32%
3 Months
-52.39%
6 Months
-48.04%
1 Year
-29.92%
2 Year
-67.81%
Key data
Stock price
$4.41
P/E Ratio 
-0.16
DAY RANGE
N/A - N/A
EPS 
-$27.92
52 WEEK RANGE
$3.42 - $9.60
52 WEEK CHANGE
-$0.27
MARKET CAP 
7.984 M
YIELD 
N/A
SHARES OUTSTANDING 
1.823 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$30,515
AVERAGE 30 VOLUME 
$48,731
Company detail
CEO:
Region: US
Website: slipchip.com
Employees: 157
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

high complexity diagnostics at the point-of-need. bridging the gap between discovery and delivery at slipchip we integrate high-complexity laboratory assays, into an easy to perform, affordable and accessible sample-to-answer format across a wide range of environments. what if physicians could make rapid, individualized optimal treatment decisions? today, patients are often forced to endure days of waiting for lab results. as a result, doctors initially treat everyone with a strong cocktail of drugs. this approach is costly and can be harmful to patients.it also leads to serious drug resistance problems. our technology will allow doctors to provide optimal therapies to patients sooner. empowering physicians to make informed treatment decisions quickly. minimizing risks and reducing patient recovery times.

Recent news